-
1
-
-
13844297030
-
Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations
-
Lambert, J.D., Hong, J., Yang, G.Y. et al. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am J Clin Nutr 2005, 81(1, Suppl.): 284S-91S.
-
(2005)
Am J Clin Nutr
, vol.81
, Issue.1 and SUPPL.
-
-
Lambert, J.D.1
Hong, J.2
Yang, G.Y.3
-
2
-
-
13844271387
-
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
-
Williamson, G., Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1, Suppl.): 243S-55S.
-
(2005)
Am J Clin Nutr
, vol.81
, Issue.1 and SUPPL.
-
-
Williamson, G.1
Manach, C.2
-
3
-
-
56149125452
-
Apoptosis by dietary agents for prevention and treatment of cancer
-
Epub ahead of print
-
Khan, N., Adhami, V.M., Mukhtar, H. Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 2008, Epub ahead of print.
-
(2008)
Biochem Pharmacol
-
-
Khan, N.1
Adhami, V.M.2
Mukhtar, H.3
-
4
-
-
38449107684
-
Cell cycle control as a basis for cancer chemoprevention through dietary agents
-
Meeran, S.M., Katiyar, S.K. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 2008, 13: 2191-202.
-
(2008)
Front Biosci
, vol.13
, pp. 2191-2202
-
-
Meeran, S.M.1
Katiyar, S.K.2
-
5
-
-
44049092395
-
The dark side of a tumor suppressor: Antiapoptotic p53
-
Jänicke, R. U., Sohn, D., Schulze-Osthoff, K. The dark side of a tumor suppressor: Antiapoptotic p53. Cell Death Differ 2008, 15(6): 959-76.
-
(2008)
Cell Death Differ
, vol.15
, Issue.6
, pp. 959-976
-
-
Jänicke, R.U.1
Sohn, D.2
Schulze-Osthoff, K.3
-
6
-
-
48449100702
-
Downregulating sphingosine kinase-1 for cancer therapy
-
Cuvillier, O. Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 2008, 2(8): 1009-20.
-
(2008)
Expert Opin Ther Targets
, vol.2
, Issue.8
, pp. 1009-1020
-
-
Cuvillier, O.1
-
7
-
-
55349140730
-
Anti-tumor activity of phenoxodiol: From bench to clinic
-
Alvero, A.B., Kelly, M., Rossi, P. Anti-tumor activity of phenoxodiol: From bench to clinic. Fut Oncol 2008, 4(4): 475-82.
-
(2008)
Fut Oncol
, vol.4
, Issue.4
, pp. 475-482
-
-
Alvero, A.B.1
Kelly, M.2
Rossi, P.3
-
8
-
-
31544466555
-
Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells
-
Alvero, A.B., O'Malley, D., Brown, D. et al. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 2006, 106(3): 599-608.
-
(2006)
Cancer
, vol.106
, Issue.3
, pp. 599-608
-
-
Alvero, A.B.1
O'Malley, D.2
Brown, D.3
-
9
-
-
0037854571
-
Phenoxodiol - an isoflavone analog - induces apoptosis in chemoresistant ovarian cancer cells
-
Kamsteeg, M., Rutherford, T., Sapi, E. at al. Phenoxodiol - an isoflavone analog - induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 2003, 22(17): 2611-20.
-
(2003)
Oncogene
, vol.22
, Issue.17
, pp. 2611-2620
-
-
Kamsteeg, M.1
Rutherford, T.2
Sapi, E.3
at al4
-
10
-
-
33846973344
-
-
Kluger, H.M., McCarthy, M.M., Alvero, A.B. et al. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization. J Transl Mad 2007, 5: 6-20.
-
Kluger, H.M., McCarthy, M.M., Alvero, A.B. et al. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization. J Transl Mad 2007, 5: 6-20.
-
-
-
-
11
-
-
0036765743
-
Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific
-
Baudhuin, L.M., Cristina, K.L., Ju, J. et al. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. Mol Pharmacol 2002, 62(3): 660-71.
-
(2002)
Mol Pharmacol
, vol.62
, Issue.3
, pp. 660-671
-
-
Baudhuin, L.M.1
Cristina, K.L.2
Ju, J.3
-
12
-
-
0038447079
-
Sphingosine-1-phosphate promotes mouse melanocyte survival via ERK and Akt activation
-
Kim, D.S., Hwang, E.S., Lee, J.E., Kim, S.Y., Park, K.C. Sphingosine-1-phosphate promotes mouse melanocyte survival via ERK and Akt activation. Cell Signal 2003, 15(10): 919-26.
-
(2003)
Cell Signal
, vol.15
, Issue.10
, pp. 919-926
-
-
Kim, D.S.1
Hwang, E.S.2
Lee, J.E.3
Kim, S.Y.4
Park, K.C.5
-
13
-
-
52449092057
-
Targeting Sp hK1 as a new strategy against cancer
-
Shida, D., Takabe, K., Kapitonov, D. et al. Targeting Sp hK1 as a new strategy against cancer. Curr Drug Targets 2008, 9(8): 662-73.
-
(2008)
Curr Drug Targets
, vol.9
, Issue.8
, pp. 662-673
-
-
Shida, D.1
Takabe, K.2
Kapitonov, D.3
-
14
-
-
0034084510
-
Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells
-
Kim, W.H., Kang, K.H., Kim, M.Y. et al. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells. Biochem Cell Biol 2000, 78(2): 127-35.
-
(2000)
Biochem Cell Biol
, vol.78
, Issue.2
, pp. 127-135
-
-
Kim, W.H.1
Kang, K.H.2
Kim, M.Y.3
-
15
-
-
0037203342
-
Ceramide in apoptosis: An overview and current perspectives
-
Pettus, B.J., Chalfant, C.E., Hannun, Y.A. Ceramide in apoptosis: An overview and current perspectives. Biochim Biophys Acta 2002, 1585(2-3): 114-25.
-
(2002)
Biochim Biophys Acta
, vol.1585
, Issue.2-3
, pp. 114-125
-
-
Pettus, B.J.1
Chalfant, C.E.2
Hannun, Y.A.3
-
16
-
-
42649126006
-
Ceramide-induced cell death in malignant cells
-
Carpinteiro, A., Dumitru, C., Schenck, M., Gulbins, E. Ceramide-induced cell death in malignant cells. Cancer Lett 2008, 264(1): 1-10.
-
(2008)
Cancer Lett
, vol.264
, Issue.1
, pp. 1-10
-
-
Carpinteiro, A.1
Dumitru, C.2
Schenck, M.3
Gulbins, E.4
-
17
-
-
33746068256
-
NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis
-
De Luca, T., Morre, D.M., Zhao, H. et al. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. Biofactors 2005, 25(1-4): 43-60.
-
(2005)
Biofactors
, vol.25
, Issue.1-4
, pp. 43-60
-
-
De Luca, T.1
Morre, D.M.2
Zhao, H.3
-
18
-
-
55349130707
-
Phenoxodiol, a synthetic analog of genistein, generates ceramide and is equipotent in wild-type and multidrug-resistant human tumour cells
-
ASCO, May 13-17, Orlando, Abst 2075
-
Cabot, M.C., Yu, J.Y., Kelly, G.E. et al. Phenoxodiol, a synthetic analog of genistein, generates ceramide and is equipotent in wild-type and multidrug-resistant human tumour cells. 41st Annu Meet Am Soc Clin Oncol (ASCO) (May 13-17, Orlando) 2005, Abst 2075.
-
(2005)
41st Annu Meet Am Soc Clin Oncol
-
-
Cabot, M.C.1
Yu, J.Y.2
Kelly, G.E.3
-
19
-
-
33646426132
-
Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects
-
Gamble, J.R., Xia, P., Hahn, C.N. et al. Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. Int J Cancer 2006, 118(10): 2412-20.
-
(2006)
Int J Cancer
, vol.118
, Issue.10
, pp. 2412-2420
-
-
Gamble, J.R.1
Xia, P.2
Hahn, C.N.3
-
20
-
-
34250339627
-
ECTO-NOX target for the anticancer isoflavone phenoxodiol
-
Morre, D.J., Chueh, P.J., Yagiz, K. et al. ECTO-NOX target for the anticancer isoflavone phenoxodiol. Oncol Res 2007, 16(7): 299-312.
-
(2007)
Oncol Res
, vol.16
, Issue.7
, pp. 299-312
-
-
Morre, D.J.1
Chueh, P.J.2
Yagiz, K.3
-
21
-
-
24644523642
-
Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer
-
Brown, D.M., Kelly, G.E., Husband, A.J. Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer. Mol Biotechnol 2005, 30(3): 253-70.
-
(2005)
Mol Biotechnol
, vol.30
, Issue.3
, pp. 253-270
-
-
Brown, D.M.1
Kelly, G.E.2
Husband, A.J.3
-
22
-
-
17144381683
-
Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1
-
Aguero, M.F., Facchinetti, M.M., Shelag, Z. et al. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Res 2005, 65(8): 3364-73.
-
(2005)
Cancer Res
, vol.65
, Issue.8
, pp. 3364-3373
-
-
Aguero, M.F.1
Facchinetti, M.M.2
Shelag, Z.3
-
23
-
-
19944430097
-
Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol
-
Sapi, E., Alvero, A.B., Chen, W. et al. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res 2004, 14(11-12): 567-78.
-
(2004)
Oncol Res
, vol.14
, Issue.11-12
, pp. 567-578
-
-
Sapi, E.1
Alvero, A.B.2
Chen, W.3
-
24
-
-
34548254858
-
Phenoxodiol-topotecan coadministration exhibit significant anti-tumor activity without major adverse side effects
-
Alvaro, A.B., Brown, D., Montagna, M. et al. Phenoxodiol-topotecan coadministration exhibit significant anti-tumor activity without major adverse side effects. Cancer Biol Ther 2007, 6(4): 612-7.
-
(2007)
Cancer Biol Ther
, vol.6
, Issue.4
, pp. 612-617
-
-
Alvaro, A.B.1
Brown, D.2
Montagna, M.3
-
25
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou, T.C., Talalay, P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984, 22: 27-55.
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
26
-
-
0030919715
-
Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3
-
Kanzawa, F., Nishio, K., Fukuoka, K., Fukuda, M., Kunimoto, T., Saijo, N. Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3. Int J Cancer 1997, 71(3): 311-9.
-
(1997)
Int J Cancer
, vol.71
, Issue.3
, pp. 311-319
-
-
Kanzawa, F.1
Nishio, K.2
Fukuoka, K.3
Fukuda, M.4
Kunimoto, T.5
Saijo, N.6
-
27
-
-
0036619301
-
Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: Possible involvement of the phosphoinositide-3 kinase/Akt pathway
-
Cheng, J.Q., Jiang, X., Fraser, M. et al. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: Possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist Updat 2002, 5(3-4): 131-46.
-
(2002)
Drug Resist Updat
, vol.5
, Issue.3-4
, pp. 131-146
-
-
Cheng, J.Q.1
Jiang, X.2
Fraser, M.3
-
28
-
-
0034104017
-
Apoptosis and chemoresistance in human ovarian cancer: Is Xiap a determinant?
-
Li, J., Sasaki, H., Sheng, Y.L. et al. Apoptosis and chemoresistance in human ovarian cancer: Is Xiap a determinant? Biol Signals Recept 2000, 9(2): 122-30.
-
(2000)
Biol Signals Recept
, vol.9
, Issue.2
, pp. 122-130
-
-
Li, J.1
Sasaki, H.2
Sheng, Y.L.3
-
29
-
-
0036463649
-
Apoptosis-based therapies
-
Reed, J.C. Apoptosis-based therapies. Nat Rev Drug Discov 2002, 1(2): 111-21.
-
(2002)
Nat Rev Drug Discov
, vol.1
, Issue.2
, pp. 111-121
-
-
Reed, J.C.1
-
30
-
-
0035266318
-
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells
-
Asselin, E., Mills, G.B., Tsang, B.K. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 2001, 61(5): 1862-8.
-
(2001)
Cancer Res
, vol.61
, Issue.5
, pp. 1862-1868
-
-
Asselin, E.1
Mills, G.B.2
Tsang, B.K.3
-
31
-
-
37849030454
-
Modulation of apoptosis to reverse chemoresistance
-
Mor, G., Montagna, M. K., Alvero, A.B. Modulation of apoptosis to reverse chemoresistance. Methods Mol Biol 2008, 414: 1-12.
-
(2008)
Methods Mol Biol
, vol.414
, pp. 1-12
-
-
Mor, G.1
Montagna, M.K.2
Alvero, A.B.3
-
32
-
-
0035955293
-
3H]Dofetilide binding to HERG transfected membranes: A potential high throughput preclinical screen
-
Finlayson, K., Turnbull, L., January, C.T. et al. [3H]Dofetilide binding to HERG transfected membranes: A potential high throughput preclinical screen. Eur J Pharmacol 2001, 430(1): 147-8.
-
(2001)
Eur J Pharmacol
, vol.430
, Issue.1
, pp. 147-148
-
-
Finlayson, K.1
Turnbull, L.2
January, C.T.3
-
33
-
-
33646167077
-
Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer
-
Choueiri, T.K., Mekhail, T., Hutson, T.E. et al. Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer. Ann Oncol 2006, 17(5): 860-5.
-
(2006)
Ann Oncol
, vol.17
, Issue.5
, pp. 860-865
-
-
Choueiri, T.K.1
Mekhail, T.2
Hutson, T.E.3
-
34
-
-
0942287951
-
Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma
-
ten Bokkel, H.W., Lane, S.R., Ross, G.A. Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma. Ann Oncol 2004, 15(1): 100-3.
-
(2004)
Ann Oncol
, vol.15
, Issue.1
, pp. 100-103
-
-
ten Bokkel, H.W.1
Lane, S.R.2
Ross, G.A.3
-
35
-
-
0037631528
-
Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer
-
Ghamande, S., Lele, S., Marchetti, D. et al. Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer. Int J Gynecol Cancer 2003, 13(2): 142-7.
-
(2003)
Int J Gynecol Cancer
, vol.13
, Issue.2
, pp. 142-147
-
-
Ghamande, S.1
Lele, S.2
Marchetti, D.3
|